iRadimed
iRadimed

iRadimed

Health Care Equipment & Supplies
WebsiteInvestor RelationsSEC
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

$1.1B

Market Cap • 10/2/2026

1992

(34 years)

Founded

2014

(12 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

10,7

P/S

12,6

P/EBITDA

37,4

P/OCF

40,2

P/FCF

43,5

P/E

47,7

BVPS

8

EPS

1,8

Market Cap

Market Cap

1,1B

EV

1B

EV/Revenue

12

EV/EBITDA

35,4

EV/EBIT

37,5

Payout

Dividend Per Share

1,2

Dividend Yield

1,5%

Buyback Yield

0,2%

Total Yield

1,7%

Dividend Yield 5Y

1,6%

Payout

68,7%

Retained Earnings

70,2M

Profitability

Gross Margin

75,9%

EBITDA Margin

33,8%

EBIT Margin

31,9%

Net Margin

26,7%

D&A/EBITDA

0%

R&D/Revenue

3,6%

Capex/Revenue

2,3%

Capex/D&A

124%

Capex/OCF

7,4%

SBC/OCF

10,5%

% PPE

21,1%

% Goodwill

0%

ROE

23,5%

ROIC

46,8%

Growth

CAGR Revenue 5Y

19,6%

CAGR Op. Income 5Y

40,4%

CAGR Net Income 5Y

38,2%

CAGR EPS 5Y

37,1%

CAGR OCF 5Y

26,6%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

9,5

Quick Ratio

7,9

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium